Activation of the IL-1β/IL-1R1 signaling pathway increased AML LSC proliferation and antibodies against IL1RAP suppressed IL-1β induced proliferation (Askmyr et al., 2013; Ågerstam et al., 2015). Here, IL1B is linked to acute myeloid leukemia.